Syngenta and DuPont Agree on Technology Exchange to Launch New Fungicide Solutions

   Syngenta and DuPont Agree on Technology Exchange to Launch New Fungicide
                                  Solutions

PR Newswire

BASEL, Switzerland and WILMINGTON, Delaware, May 14, 2013

BASEL, Switzerland and WILMINGTON, Delaware, May 14, 2013 /PRNewswire/ --

Syngenta and DuPont today announced technology licensing agreements that will
broaden each company's crop protection product portfolio and enable both to
bring new products to market more efficiently.

Syngenta has obtained a global license from DuPont to develop products
containing DuPont's fungicide oxathiapiprolin. The development of this new
piperidinyl thiazole isoxazoline class of fungicides represents a significant
improvement for growers in the control of diseases in potatoes, grapes,
vegetables and other specialty crops.

Under the agreements, Syngenta receives exclusive rights for foliar and soil
uses on all crops in North America and for lawn and garden uses globally.
Syngenta also secures rights on certain crops for seed treatment globally and
for the development of foliar and soil uses on certain crops outside of North
America.  

The agreement gives DuPont exclusive access to Syngenta's Solatenol™for
mixture with DuPont's picoxystrobin fungicide on soybean and other crops in
Brazil. Solatenol™ is a new benz-pyrazole SDHI fungicide which brings a new
mode of action with no cross-resistance to existing fungicides. It offers
outstanding and long-lasting control of Asian rust in soybean.

"These agreements again demonstrate DuPont Crop Protection's commitment to our
customers by collaborating to deliver innovative products from our robust
pipeline while always focusing on sustainability and maximizing shareholder
value," said Rik Miller, president DuPont Crop Protection. "This decision
enables DuPont to provide solutions that will help our customers improve their
productivity and profitability now and in the future." 

Syngenta's Chief Operating Officer John Atkin said: "Access to oxathiapiprolin
will further broaden our world-leading fungicide portfolio. Diverse modes of
action are critical for disease control and to sustain the lifecycle of
existing products in the face of resistance challenges. We are also pleased
that this agreement will contribute to maximizing the market coverage of
Solatenol™ in Brazil."

The transaction is subject to approvals from applicable regulatory
authorities. Financial terms of the agreement were not disclosed.

About Syngenta

Syngenta is one of the world's leading companies with more than 27,000
employees in over 90countries dedicated to our purpose: Bringing plant
potential to life. Through world-class science, global reach and commitment to
our customers we help to increase crop productivity, protect the environment
and improve health and quality of life. For more information about us please
go to http://www.syngenta.com

SOLATENOL™ is a trademark of a Syngenta Group Company

About DuPont

DuPont (NYSE: DD) has been bringing world-class science and engineering to the
global marketplace in the form of innovative products, materials, and services
since 1802. The company believes that by collaborating with customers,
governments, NGOs, and thought leaders we can help find solutions to such
global challenges as providing enough healthy food for people everywhere,
decreasing dependence on fossil fuels, and protecting life and the
environment. For additional information about DuPont and its commitment to
inclusive innovation, please visit http://www.dupont.com.

The DuPont Oval Logo, DuPont™, The miracles of science™, are registered
trademarks of DuPont or its affiliates.

Cautionary Statement Regarding Forward-Looking Statements

Syngenta: This document contains forward-looking statements, which can be
identified by terminology such as 'expect', 'would', 'will', 'potential',
'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar
expressions. Such statements may be subject to risks and uncertainties that
could cause the actual results to differ materially from these statements. We
refer you to Syngenta's publicly available filings with the U.S. Securities
and Exchange Commission for information about these and other risks and
uncertainties. Syngenta assumes no obligation to update forward-looking
statements to reflect actual results, changed assumptions or other factors.
This document does not constitute, or form part of, any offer or invitation to
sell or issue, or any solicitation of any offer, to purchase or subscribe for
any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the
basis of, or be relied on in connection with, any contract therefor.

Cautionary Statements Regarding Forward-Looking Information:

DuPont: This news release contains forward-looking statements based on
management's current expectations, estimates and projections. All statements
that address expectations or projections about the future, including
statements about the company's strategy for growth, product development,
market position, expected expenditures and financial results are
forward-looking statements. Some of the forward-looking statements may be
identified by words like "expects," "anticipates," "plans," "intends,"
"projects," "indicates," and similar expressions. These statements are not
guarantees of future performance and involve a number of risks, uncertainties
and assumptions. Many factors, including those discussed more fully elsewhere
in this release and in documents filed with the Securities and Exchange
Commission by DuPont, particularly its latest annual report on Form 10-K and
quarterly report on Form 10-Q, as well as others, could cause results to
differ materially from those stated. These factors include, but are not
limited to changes in the laws, regulations, policies and economic conditions,
including inflation, interest and foreign currency exchange rates, of
countries in which the company does business; competitive pressures;
successful integration of structural changes, including restructuring plans,
acquisitions, divestitures and alliances; cost of raw materials, research and
development of new products, including regulatory approval and market
acceptance; seasonality of sales of agricultural products; and severe weather
events that cause business interruptions, including plant and power outages,
or disruptions in supplier and customer operations. The company undertakes no
duty to update any forward-looking statements as a result of future
developments or new information.

SyngentaInternationalAG

Media Office
Schwarzwaldallee 215
CH-4002Basel
Switzerland
Telephone:  +41-61-323-23-23
Fax: +41-61-323-24-24
http://www.syngenta.com

Syngenta Media contact:

Paul Barrett
Switzerland  +41-61-323-2323
media.relations@syngenta.com

Syngenta Analyst/Investor contact:

Jennifer Gough
Switzerland+41-61-323-5059
USA+1-202-737-6521



DuPont

Media Office
10^th & Market Streets
Wilmington, DE
United States
Telephone:  +1-302-774-4805
http://www.dupont.com

DuPont Media contact:

Gregg M. Schmidt
USA+1-302-999-3330
gregg.m.schmidt@dupont.com

DuPont Analyst/Investor contact:

Timothy A. Johnson
USA+1-515-535-2177
Timothy.a.johnson@dupont.com

SOURCE SYNGENTA CROP PROTECTION AG
 
Press spacebar to pause and continue. Press esc to stop.